Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective (Q36801006)

16 August 2017

1 reference

title

Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective (English)

1 reference

Christodoulos I. Stefanadis

16 August 2017

1 reference

series ordinal

7

object named as

Christodoulos Stefanadis

1 reference

16 August 2017

1

Dimitris Tousoulis

1 reference

16 August 2017

6

Elli Stefanadi

1 reference

16 August 2017

4

Gerasimos Siasos

1 reference

16 August 2017

5

Gerasimos Siasos

1 reference

16 August 2017

Rainer H Böger

2

1 reference

PubMed ID

17457351

16 August 2017

Charalambos Antoniades

series ordinal

3

1 reference

16 August 2017

1 May 2007

1 reference

Nature Clinical Practice Cardiovascular Medicine

16 August 2017

1 reference

16 August 2017

4

1 reference

16 August 2017

5

1 reference

16 August 2017

274-283

1 reference

Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.

16 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

Effects of L-arginine on atherogenesis and endothelial dysfunction due to secondhand smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

Enhanced monocyte tissue factor response after experimental balloon angioplasty in hypercholesterolemic rabbit: inhibition with dietary L-arginine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

L-arginine in cardiovascular disease: dream or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Hypoxia induces a functionally significant and translationally efficient neuronal NO synthase mRNA variant

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Regulation of the expression of inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Endothelial nitric oxide synthase in vascular disease: from marvel to menace

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

A novel nonenzymatic pathway for the generation of nitric oxide by the reaction of hydrogen peroxide and D- or L-arginine

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Continuous perivascular L-arginine delivery increases total vessel area and reduces neointimal thickening after experimental balloon dilatation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Local L-arginine delivery after balloon angioplasty reduces monocyte binding and induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Serum cholesterol level, cigarette smoking, and vasomotor responses to L-arginine in narrowed epicardial coronary arteries

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Effects of vitamin C on intracoronary L-arginine dependent coronary vasodilatation in patients with stable angina

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Effect of local delivery of L-arginine on in-stent restenosis in humans

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Oral L-arginine improves endothelial function in healthy individuals older than 70 years

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Effects of in vivo and in vitro L-arginine supplementation on healthy human vessels.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Clinical and inflammatory effects of dietary L-arginine in patients with intractable angina pectoris

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Randomized trial of a medical food for the dietary management of chronic, stable angina

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Oral L-arginine (and other active ingredients) for ischemic heart disease?.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Oral L-arginine in patients with coronary artery disease on medical management

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Arginine intake and risk of coronary heart disease mortality in elderly men

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Adverse effects of supplemental L-arginine in atherosclerosis: consequences of methylation stress in a complex catabolism?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

L-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Dietary l -Arginine Reduces the Progression of Atherosclerosis in Cholesterol-Fed Rabbits

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Combination therapy of cholesterol reduction and L-arginine supplementation controls accelerated vein graft atheroma

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: effects on neointimal hyperplasia and vascular remodeling

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Dietary l-arginine and α-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0878

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO0878

1 reference

16 August 2017

1 reference

PubMed ID

17457351